相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ethical considerations about the collection of biological samples for genetic analysis in clinical trials
Ines Galende-Dominguez et al.
RESEARCH ETHICS (2023)
Healthcare professionals' knowledge, confidence and perceptions of pharmacogenomics in primary care and pain management
Matthew P. Behr et al.
PHARMACOGENOMICS (2023)
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial
Cornelis F. Vos et al.
JAMA NETWORK OPEN (2023)
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
Tristan M. Sissung et al.
CANCERS (2022)
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials
Lisa C. Brown et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
An overview of Personalized Medicine landscape and policies in the European Union
F. Beccia et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2022)
Pharmacogenetics to guide cardiovascular drug therapy
Julio D. Duarte et al.
NATURE REVIEWS CARDIOLOGY (2021)
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Michelle Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L. Pereira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
Marty Chaplin et al.
PLOS MEDICINE (2020)
Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies
Marty Richardson et al.
BMJ OPEN (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
Francesca Maria Notarangelo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention
Kalliopi Gerogianni et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J. Caraballo et al.
GENETICS IN MEDICINE (2017)
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty The GIFT Randomized Clinical Trial
Brian F. Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Clinicians' perceptions of pharmacogenomics use in psychiatry
Christopher Yi Wen Chan et al.
PHARMACOGENOMICS (2017)
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
M. Verbelen et al.
PHARMACOGENOMICS JOURNAL (2017)
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions
Catrin O. Plumpton et al.
PHARMACOECONOMICS (2016)
Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
Shih-Chi Su et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study
Thomas O. Bergmeijer et al.
AMERICAN HEART JOURNAL (2014)
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Kelly E. Caudle et al.
CURRENT DRUG METABOLISM (2014)
Through a Glass Darkly: Economics and Personalised Medicine
Alan Haycox et al.
PHARMACOECONOMICS (2014)
Pharmacogenomics in oncology care
Kelly K. Filipski et al.
FRONTIERS IN GENETICS (2014)
Pharmacogenomics in early-phase clinical development
Tal Burt et al.
PHARMACOGENOMICS (2013)
Primary care physicians' knowledge of and experience with pharmacogenetic testing
S. B. Haga et al.
CLINICAL GENETICS (2012)
Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
J. M. Pulley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Attitudes of Health Care Professionals Toward Pharmacogenetic Testing
Nathalie K. Zgheib et al.
MOLECULAR DIAGNOSIS & THERAPY (2011)
The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pharmacogenomic biomarkers for prediction of severe adverse drug reactions
Magnus Ingelman-Sundberg
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report
OP Corrigan
JOURNAL OF MEDICAL ETHICS (2005)
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education
D Gurwitz et al.
PHARMACOGENOMICS JOURNAL (2005)
Pharmacogenomics of psychiatric disorders
D Pickar et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)